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Abstract
Introduction. The positive impact of substance use treatment is well-evidenced but there has been substantial disinvestment
from publicly funded treatment services in England since 2013/2014. This paper examines whether this disinvestment from
adult alcohol and drug treatment provision was associated with changes in treatment and health outcomes, including: treat-
ment access, successful completions from treatment, alcohol-specific hospital admissions, alcohol-specific mortality and drug-
related deaths. Methods. Annual administrative data from 2013/2014 to 2018/2019 was matched at local government level
and multi-level time series analysis using linear mixed-effect modelling conducted for 151 upper-tier local authorities in
England. Results. Between 2013/2014 and 2018/2019, £212.2 million was disinvested from alcohol and drug treatment
services, representing a 27% decrease. Concurrently, 11% fewer people accessed, and 21% fewer successfully completed, treat-
ment. On average, controlling for other potential explanatory factors, a £10 000 disinvestment from alcohol and drug treat-
ment services was associated with reductions in all treatment outcomes, including 0.3 fewer adults in treatment (95%
confidence interval 0.16–0.45) and 0.21 fewer adults successfully completing treatment (95% % confidence interval
0.12–0.29). A £10 000 disinvestment from alcohol treatment was not significantly associated with changes in alcohol-specific
hospital admissions or mortality, nor was disinvestment from drug treatment associated with the rate of drug-related deaths.
Discussion and Conclusions. Local authority spending cuts to alcohol and drug treatment services in England were asso-
ciated with fewer people accessing and successfully completing alcohol and drug treatment but were not associated with changes
in related hospital admissions and deaths. [Roscoe S, Pryce R, Buykx P, Gavens L, Meier PS. Is disinvestment from
alcohol and drug treatment services associated with treatment access, completions and related harm? An analysis of
English expenditure and outcomes data. Drug Alcohol Rev 2021]
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Introduction
Despite the wealth of evidence that alcohol and drug
treatment are effective at reducing health and social
harms [1–4], there has recently been substantial disin-
vestment from publicly-funded treatment systems in
various countries [5–9]. Worldwide each year, over
3 million lives are lost due to the misuse of alcohol and
the non-medical use of opioids is associated with pre-
mature deaths [4,10]. Global disability-adjusted life
years attributable to alcohol and drugs are over 99 mil-
lion and almost 32 million, respectively [11]. Due to
the recognised burden, reducing the harm from the
misuse of alcohol and drugs, through prevention and
treatment, are global health priorities [12].
Public health investment provides a good return on
investment in terms of health outcomes [13,14]. Effec-
tive substance use treatment improves health and
social outcomes for individuals, families and commu-
nities [15,16]. This includes reduced consumption
and abstinence [17], a reduction in risk-taking behav-
iour [18], reduced offending [19,20] and reduced
mortality [4,21,22].
In England, the majority of treatment services are
publicly funded via the Public Health Grant [23]. The
Health and Social Care Act 2012 transferred many
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public health responsibilities from the National Health
Services, and an allocated Public Health Grant, to
152 England local government areas. Each local
authority, serving a mean population of 297 286
(SD 226761), were made responsible for the adminis-
tration of the grant. Included within the transfer of
responsibilities was the commissioning of alcohol and
drug treatment services, and the protected status of the
alcohol and drug budget—which prevented it being
spent on other public health priorities—was removed
[24]. At the same time, England experienced a
national government-led austerity program, resulting
in sustained reductions in total local authority funding.
This amounted to estimated losses of £9.8 billion
(38%) between 2009/2010 and 2018/2019 [25],
including a £700 million (15%) reduction between
2015/2016 and 2019/2020 in the Public Health
Grant [26].
A recently-published study examined the relation-
ship between specialist alcohol treatment provision,
alcohol-related admissions and deprivation in England
[27]. However, to our knowledge, no previous studies
have been conducted to assess the relationship
between disinvestment from alcohol and drug treat-
ment services and changes in treatment access or out-
comes at a local authority level.
This paper contributes to the literature by examining
how changes in alcohol and drug treatment investment
in English local authorities between 2013/2014 and
2018/2019 were associated with changes in treatment




The units of analysis in this study were 151 of the
152 upper tier local authorities (local government
offices) in England. The Isles of Scilly were excluded
from analysis due to alcohol and drug treatment and
mortality data not being available for the authority.
The data is taken for the financial years 2013/2014 to
2018/2019 inclusive.
The main variable of interest is expenditure on treat-
ment services from the Public Health Grant. This data
is extracted from each local authority’s publicly avail-
able General Fund Revenue Account Outturn [28].
Net expenditure data are available from 2013/2014
onwards for alcohol and drugs separately. For
2013/2014 and 2014/2015, the figure reported for each
substance type included all activities (i.e. treatment,
prevention and harm reduction). However, from
2015/2016 to 2018/2019, the reported spend was
separated into ‘treatment’ and ‘prevention/harm
reduction’ streams. We added these streams together
to enable comparison of net expenditure across years.
Expenditure data were converted into real terms using
the Retail Price Index with 2013/2014 as the baseline
year [29].
The treatment outcomes of interest were obtained
from the National Drug Treatment Monitoring System
via Public Health England [30], which compiles data
about all people accessing publicly-funded structured
treatment [17]. For each local authority, we used data
on the number of adults who were: (i) in treatment;
(ii) new to treatment (within that year); (iii) leaving
treatment successfully free of dependence; and (iv)
leaving treatment successfully and not returning to
treatment within 6 months. Treatment data classify
treatment into four categories: ‘alcohol only’, ‘opiate’,
‘non-opiate only’ and ‘alcohol and non-opiate’.
The health outcomes of interest are: (i) alcohol-
specific hospital admissions, which are admissions
where the primary or secondary diagnosis is wholly
attributable to alcohol [31]; (ii) alcohol-specific mor-
tality where the cause of death is wholly attributable to
alcohol [32]; and (iii) drug-related deaths [33]. Due
to small counts health outcomes (ii) and (iii) were
pooled over two financial years. The time lag to data
publication meant that data for local authorities were
only available for 4 years for alcohol-specific and
5 years for drug-related mortality.
Summary statistics for treatment expenditure are
presented in Table 1. The majority (88%) of local
authorities saw a decrease in total substance treatment
expenditure. Between 2013/2014 and 2018/2019 a
total of £212 million was disinvested from treatment.
Statistical analysis
Paired t-tests were used to examine the change in each
variable over the sample period. The main analysis
used multi-level linear mixed-effect models. Linear
mixed-effect models are flexible models that enable
regression using longitudinal data with continuous
dependent variables [34]. Local authorities, population
size [35] and financial year were adjusted for as fixed
effects. The local authority fixed effect controls for
unobserved heterogeneity across local authorities,
accounting for time-invariant characteristics. The
inclusion of financial year as a fixed effects controls for
secular time trend effects which affect every local
authority and pick up factors such as increased pre-
scribing costs. Due to the recent integration of many
community alcohol services with drug treatment
[5,36], analyses examined combined alcohol and drug
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(hereafter “substance use”) treatment data as well as
alcohol (alcohol only) and drug (opiate and non-opi-
ate) treatment independently.
The regression equation used was:
Y it ¼ αþβ1INVESTMENT it þβ2POP it þδiþδtþ εit
where Yit denotes the outcome of interest in local
authority i in financial year t. Separate regressions were
run for alcohol, drugs and total substance use. In each
case, the independent variable was the substance-
specific investment. For example, we estimated the
relationship between the investment in alcohol treat-
ment and the number of people accessing alcohol
treatment services. The separate alcohol and drug
treatment analysis excluded the ‘non-opiate and alco-
hol’ treatment numbers as, unlike the other cohorts,
there is no set classification as to whether a person in
this cohort accessed alcohol treatment or drug treat-
ment. For robustness, we included non-opiate and
alcohol cohort numbers in the dependent variable for
the modelling of binary alcohol and drug treatment
analyses. This made little difference to the results and
can be found in Table A1, Appendix.
As the focus of this study is the relationship between
disinvestment and treatment and health outcomes, the
model results are presented in terms of ‘per £10,000
disinvested’.
Ethics and public involvement
This research was granted ethical approval by the Uni-
versity of Sheffield School of Health and Related
Research ethics board. The Sheffield Addiction Recov-
ery Research Panel, a group of people with lived expe-
rience of alcohol and drug dependence established to
shape alcohol and drug-related research, was consulted
on the research questions and design before analysis.
Results
Paired t-tests
The results from the paired t-tests are presented in
Table 2. There was statistically significant disinvest-
ment from substance use treatment and drug treat-
ment between 2013/2014 and 2018/2019. The small
decrease in the amount invested in alcohol treatment
was not statistically significant. The decline in invest-
ment was consistent over the 6 years with the excep-
tion of the money invested in alcohol treatment, which
rose to a peak in 2015/2016.
Concurrently, there was a significant decline in all
observed treatment outcomes. This includes an
observed 33 580 fewer people accessing treatment,
15 060 fewer people new to treatment, 14 330 fewer
people successfully completing treatment and 11 785
fewer successfully completing treatment and not
returning within 6 months. There was a statistically
significant decrease in all alcohol treatment outcomes.
Table 2 also shows statistically significant increases in
alcohol-specific hospital admissions, alcohol-specific
mortality and drug-related deaths.
Linear mixed-effects models
Table 3 shows that disinvestment from substance use
treatment services was related to reductions in the
number of adults in substance use treatment, new to
substance use treatment, successfully completing sub-
stance use treatment and successfully completing
Table 1. Patterns in local authority changes in treatment expenditure between 2013/2014 and 2018/2019
Increased or decreased investment in
treatment
Number of local
authorities n and (%a)
Total change in treatment expenditure £m (SD)
Substance use Alcohol Drug Substance use Alcohol Drug
Increased Increased Increased 5 (3) +£5.83 (1.81) +£0.84 (0.15) +£4.99 (1.19)
Increased Increased Decreased 4 (3) +£1.41 (0.59) +£4.49 (1.56) £3.09 (0.97)
Increased Decreased Increased 6 (4) +£11.31 (2.2) £5.40 (1.10) +£16.71 (2.97)
Decreased Increased Decreased 67 (44) £114.11 (1.68) +£45.73 (0.78) £159.98 (2.21)
Decreased Decreased Increased 8 (5) £6.96 (0.75) £11.47 (1.16) +£4.51 (0.72)
Decreased Decreased Decreased 61 (40) £109.68 (1.50) £34.80 (0.70) £74.89 (1.09)
Total net change in spend: £212.21 (1.79) £0.60 (1.06) £211.61 (2.13)
aPercentages do not sum to 100 due to rounding.
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Table 2. Annual changes in investment, treatment and health variables between 2013/2014 and 2018/2019 with paired t-test results










5283 (3449) 5249 (3513) 4933 (3190) 4619 (2996) 4202 (2778) 3878 (2506) 27% 1405
(1795)
<0.001
Number in treatment 1999 (1321) 1955 (1286) 1913 (1252) 1851 (1210) 1776 (1136) 1777 (1125) 11% 222 (426) <0.001
Number new to
treatment
974 (650) 937 (623) 913 (601) 868 (562) 842 (539) 875 (539) 10% 100 (300) <0.001
Number of successful
completions





440 (328) 443 (327) 417 (293) 404 (283) 385 (269) 362 (249) 18% 78 (197) <0.001
Alcohol Money invested in
treatment (£000 s)
1333 (1266) 1355 (1256) 1537 (1352) 1516 (1300) 1412 (1112) 1329 (1019) - < 1% 4 (1065) 0.963
Number in treatment 607 (415) 590 (398) 563 (384) 533 (360) 502 (331) 501 (333) 17% 106 (219) <0.001
Number new to
treatment
431 (305) 407 (286) 382 (268) 353 (234) 335 (231) 347 (235) 19% 84 (168) <0.001
Number of successful
completions





228 (175) 231 (172) 219 (157) 210 (153) 199 (143) 191 (138) 16% 36 (111) <0.001
Alcohol-specific
hospital admissions
(rate per 100 000)




11.2 (4.3) 11.4 (4.6) 11.6 (4.5) 11.7 (4.4) +4% 0.5 (1.9) <0.001
Drugs Money invested in
treatment (£000 s)
3950 (2890) 3894 (2984) 3396 (2417) 3103 (2326) 2790 (2246) 2548 (1815) 35% 1401
(2133)
<0.001
Number in treatment 1201 (847) 1178 (819) 1163 (800) 1132 (786) 1091 (747) 1087 (732) 9% -115 (212) <0.001
Number new to
treatment
416 (299) 408 (283) 407 (274) 395 (273) 382 (253) 394 (242) 5% 22 (129) 0.038
Number of successful
completions





147 (130) 145 (122) 135 (99) 130 (93) 122 (90) 112 (78) 24% 35 (83) <0.001
Drug related deaths
(rate per 100 000)
6.3 (2.7) 6.7 (2.9) 7.0 (3.2) 7.4 (3.4) 7.8 (3.6) — +24% +1.5 (1.8) <0.001






































































































substance use treatment without returning within
6 months.
The results show that every £10 000 disinvestments
in substance use treatment services was associated with
0.3 fewer adults in substance use treatment, 0.17 fewer
adults new to substance use treatment, 0.21
fewer adults successfully completing substance use
treatment and 0.19 fewer adults successfully complet-
ing substance use treatment and not returning within
6 months. Presented differently, this means that every
£33 003 disinvested from substance use treatment ser-
vices was associated with one less person engaged in
treatment, and every £48 780 disinvested was associ-
ated with one less person successfully completing
treatment. Overall, we estimate that the £212.21 mil-
lion disinvested from substance use treatment was
associated with 6430 fewer people in treatment, 3523
fewer people new to treatment, 4350 fewer people suc-
cessfully completing treatment and 4074 fewer suc-
cessful completions where the person does not return
to treatment within 6 months.
The relationship between changes in investment and
treatment outcomes was similar when considered for
alcohol and drugs separately. However, there were no
significant associations between disinvestment in alco-
hol treatment and numbers in alcohol treatment,
including those new to alcohol treatment.
In terms of health outcomes, there were no significant
associations between disinvestment in alcohol treatment
and changes in alcohol-specific hospital admissions or
alcohol-specific mortality, nor changes in investment in
drug treatment and drug-related deaths.
Discussion
This study has shown that reductions in treatment
expenditure were associated with reductions in the
number of people accessing and successfully complet-
ing treatment. No significant associations were found
between disinvestment and increased rates of alcohol-
specific hospital admissions, alcohol-specific mortality
or drug-related deaths, although these results need to
be interpreted with caution.
This study makes novel use of routinely collected
and publicly available financial, treatment and health
data to explore important relationships between
sustained public health grant disinvestment from alco-
hol and drug treatment and key public health out-
comes. To our knowledge, it is the first study to
provide quantitative evidence of the association
between disinvestment from alcohol and drug treat-
ment services and a reduction in treatment access and
successful completions. Furthermore, by exploring the
funding of systems, as opposed to single interventions,
we provide useful results to understand the impact of
public health disinvestment for policymakers [15].
Despite the identified association between disinvest-
ment and fewer treatment outcomes in our study, and
Table 3. Linear mixed-effects modelled relationship between disinvestment, treatment and health outcomes 2013/14 to 2018/19
Per £10 000 disinvestment from: Outcomes
All local authorities
β coefficient SE P-value
Substance use treatment (alcohol
and drug combined)
Numbers in treatment 0.303 0.075 <0.001
Numbers new to treatment 0.166 0.054 0.002
Number of successful completions 0.205 0.042 <0.001
Number of successful completions and not return
within 6 months
0.192 0.041 <0.001
Alcohol treatment Numbers in treatment 0.102 0.059 0.083
Numbers new to treatment 0.041 0.045 0.365
Number of successful completions 0.071 0.035 0.043
Number of successful completions and not return
within 6 months
0.067 0.033 0.044
Alcohol-specific hospital admissions (rate) 0.048 0.036 0.184
Alcohol-specific mortality (rate) 0.001 0.001 0.216
Drug treatment Numbers in treatment 0.133 0.027 <0.001
Numbers new to treatment 0.106 0.019 <0.001
Number of successful completions 0.060 0.014 <0.001
Number of successful completions and not return
within 6 months
0.072 0.014 <0.001
Drug related deaths (rate) 0.000 0.000 0.613
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consistent evidence of the link between treatment
and positive health outcomes [4,15,21], our study did
not find that disinvestment was related to increased
alcohol-specific admissions, alcohol-specific mortality,
nor drug-related deaths over the period we were able
to study. However, these results need to be interpreted
with caution. There are four possible explanations for
this. First, there is likely to be a time lag between
reduced consumption and health harm, especially
when using harm metrics indicative of significant dis-
ease progressions such as hospital admissions and
deaths. The full effect of disinvestment on harm may
therefore only emerge in future years. Second, a large
proportion of people who may benefit from alcohol
and drug treatment do not access support [37]. Given
that the overall majority are not in contact with ser-
vices, aggregate population-level data such as hospital
admissions or death rates are less likely to be sensitive
to changes in treatment access and completion rates.
Third, changes in treatment needs may be driving dis-
investment from treatment services. However, treat-
ment need is difficult to measure. Furthermore,
hospital admissions and mortality are used in estimat-
ing alcohol dependence prevalence which could lead
to circularity in the model. Prevalence estimates have
remained constant or increased over time while invest-
ment has decreased which suggests that the results
found in this paper are not driven by a decline in treat-
ment need. Fourth, it is possible that the lack of identi-
fied relationships between disinvestment and health
outcomes could be partially explained by a potential
shift from treatment to prevention.
Given the evidence on the positive impact of sub-
stance use treatment on health and social outcomes
and reducing cost pressures elsewhere in the system,
policymakers at a local authority and national level
may wish to use the findings from this study to help
inform future planning. Further changes to the way in
which treatment services in England are funded are
expected in April 2021, when the central government’s
public health grant will no longer be available and local
authorities will need to raise income from local busi-
ness taxes [38]. Concerns have been raised as to
whether this will prompt further disinvestment in alco-
hol and drug treatment, limiting the quality and range
of services that can be provided [39]. The coronavirus
pandemic is also predicted to further increase pressure
on public health budgets and priorities [40] and to
drive change in how treatment is delivered, with per-
haps unknown effects on costs.
Further research to examine changes in treatment
provision and, for example, treatment modalities,
intensity and duration of support, or satisfaction with
service provision, may offer additional insight. Qualita-
tive research with local authority stakeholders,
including politicians, alcohol and drug treatment strat-
egists and commissioners, could further explain deci-
sion making around (dis)investment and better
understand additional changes contributing to the
observed trends. This may also help to identify strate-
gic and commissioning practice that has helped to mit-
igate some of the potential negative consequences of
disinvestment in a local authority context. This study
could also be replicated in other high-income countries
where substance use treatment services are publicly-
funded and cost pressures are increasing [7,8], to add
to the body of evidence. Further research could also
investigate the relative effects of disinvestment in sev-
eral areas of public health given the finite resource
available. Potentially, there may be other public health
expenditures that generate higher rates or return on
investment. Future research could examine threshold
effects of cuts, similar to other studies [41].
A limitation of the study is that it uses observational
data and as such causal statements cannot be made.
An alternative explanation for our findings would be
that disinvestment might have been an appropriate
response to a drop in demand. However, this appears
less plausible given the political context of widespread
funding cuts across many public services, persistent
high rates of unmet need [42] and well-documented
concerns by treatment practitioners [6,36].
Furthermore, this study does not account for con-
textual changes during the study period that could
have influenced the observed relationship, including
changes to the way services are contracted and pro-
vided, or broader policy changes. There have been a
number of changes to the way in which alcohol and
drug treatment services have been commissioned
and provided in England [43–45], including an
increased focus on alcohol interventions, the integra-
tion of alcohol and drug services, and a new focus on
supporting people to become abstinent as part of the
recovery agenda. Within integrated treatment services
(as the majority in England now are) there may be
some pooling of alcohol and drug funding to support
particular aspects of service delivery for example phar-
macotherapy, or diversion of resource from alcohol to
drug treatment. This may explain our finding that
whilst alcohol treatment spend was fairly stable, com-
pared to drug treatment spend, there were significant
decreases in the numbers accessing and successfully
completing treatment for both groups.
Conclusions
Between 2013/2014 and 2018/2019, there was a 27%
reduction in the amount of local authority investment
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in adult substance use treatment services in England.
We estimate that the overall disinvestment of £212.21
million between 2013/2014 and 2018/2019 was related
to 6430 fewer people accessing treatment, and 4350
fewer successfully completing treatment for
substance use.
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Table A1. Linear mixed-effects modelled relationship between disinvestment, treatment and health outcomes 2013/14 to 2018/19,






All local authorities (including
non-opiate and alcohol)
β
coefficient SE P-value β coefficient SE P-value
Alcohol treatmenta Numbers in treatment 0.102 0.059 0.083 0.086 0.075 0.251
Numbers new to treatment 0.041 0.045 0.365 0.026 0.056 0.647
Number of successful completions 0.071 0.035 0.043 0.070 0.044 0.108
Number of successful completions
and not return within 6 months
0.067 0.033 0.044 0.070 0.042 0.094
Drug treatmenta Numbers in treatment 0.133 0.027 <0.001 0.135 0.033 <0.001
Numbers new to treatment 0.106 0.019 <0.001 0.102 0.026 <0.001
Number of successful completions 0.060 0.014 <0.001 0.070 0.018 <0.001
Number of successful completions
and not return within 6 months
0.072 0.014 <0.001 0.082 0.018 <0.001
aIncluding non-opiate and alcohol cohort in binary split.
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